Strategic Collaborations of Biosimulation Market offers lucrative growth opportunities during the forecast to 2027
Biosimulation is the scientific process of developing and designing biosimulators. A biosimulator is a machine that mimics biological functions in simple forms so that it may be employed in biological systems. Simple systems biology is used in medical research to study the effect of stress on the system. These systems biology simulations also help in developing inhibitors that may be used against certain disease processes.
Biosimulation is a computer-aided mathematical simulation of biological processes. In this technique, virtual patients are considered instead of clinical research patients which significantly save time and money of pharmaceutical companies involved in drug discovery research. For instance, in March 2012, Rhenovia Pharma, a pharmaceutical company, initiated drug research programs in rare, orphan, and neglected diseases such as Huntington’s disease (HD) and Duchenne muscular dystrophy (DMD). Thus, ongoing research and development activities is anticipated to propel the growth of the global biosimulation market during the forecast period.
The prominent players in the Biosimulation Market are Certara, L.P., Simulations Plus, Inc., Dassault Systèmes (Accelrys), Genedata AG, LeadScope, Inc., Compugen Inc., Schrödinger, LLC, In Silico Biosciences, Inc., Advanced Chemistry Development, Inc., Chemical Computing Group ULC, Physiomics PLC, and Pharmaceutical Product Development, LLC (Evidera).
Biosimulation is an essential component of molecular modeling and is, therefore, an important step towards producing safe drugs that can be administered to human beings. Since the introduction of molecular modeling in the field of biology, the scope of studying and modeling various systems has widened. The field of biosimulation has come of age and the simulation of complex biological processes is now a part of all research works. Due to the increasing complexity of complex biological systems, simpler models are usually used, which ought to just be as complex as needed.
Owing to the increase of pharmaceutical companies all across the globe, the demand in the global biosimulation market is also increasing. For instance, according to Invest India, there are majorly over 3000 pharma companies in India. Moreover, continues to focus on drug discovery and new launches by key market players along with the establishment of various biotech startups all over the world are augmenting the growth of the global biosimulation market.
Today, preclinical and clinical trials are conducted on a daily basis, mostly using advanced computerized technology, to test the effects of new drugs on humans. Hence, it is not surprising that biosimulation has become important in the drug discovery and development process. The use of biosimulation in drug discovery opens up avenues for the development of better therapeutic agents that can reduce the risk of various diseases. It is also believed that the use of biosimulation in drug discovery can reduce the costs involved in research and development. Hence, the potential of biosimulation in the field of medicine and agriculture is growing rapidly. However, the cost and complexity of the devices and the studies are the main restraining factors that are hindering the growth of the market.
Buy This Complete A Business Report With Flat US $2000 Off @
Key players are focusing on strategies such as acquisitions in order to expand its geographical presence and strengthen its product portfolio. For instance, in April 2014, Dassault Systèmes, a France-based company, acquired Accelrys, Inc., a software company. Through this acquisition, Dassault Systèmes strengthened its molecular chemistry capabilities. Moreover, in May 2014, Dassault Systèmes launched its new brand BIOVIA, a combination of Dassault Systèmes’ BioIntelligence, and 3DEXPERIENCE technologies and Accelrys’ life sciences and material sciences applications.
Among product & services segment, software segment is anticipated to exhibit highest CAGR during the forecast period owing to the growing adoption of biosimulation software by research organizations and increasing investment on research and development activities. For instance, Rhenovia Pharma, a biosimulation company involved in research and development, offers a wide range of biosimulation software.
Based on application, drug development segment is expected to hold significant market share during the forecast period owing to increasing research investments for advanced software in biosimulation market.
Main points in Biosimulation Market Report Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Biosimulation Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Biosimulation Industry Impact
Chapter 2 Global Biosimulation Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biosimulation (Volume and Value) by Type
2.3 Global Biosimulation (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Biosimulation Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Biosimulation Market Analysis
Chapter 6 East Asia Biosimulation Market Analysis
Chapter 7 Europe Biosimulation Market Analysis
Chapter 8 South Asia Biosimulation Market Analysis
Chapter 9 Southeast Asia Biosimulation Market Analysis
Chapter 10 Middle East Biosimulation Market Analysis
Chapter 11 Africa Biosimulation Market Analysis
Chapter 12 Oceania Biosimulation Market Analysis
Chapter 13 South America Biosimulation Market Analysis
Chapter 14 Company Profiles and Key Figures in Biosimulation Business
Chapter 15 Global Biosimulation Market Forecast (2021-2027)
Chapter 16 Conclusions
View Press Release For More Information
Laboratory Information Systems Market, By Component Type (Software, Hardware, Services), By Delivery Mode (On Premise, Cloud-Based), By End User (Hospitals, Clinics, Independent Laboratories, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) – Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027
Clinical Data Management Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2019-2027
Digital Medicines Market ,by Technology (Mobile Health, Telehealth, Wireless Health, EMR/EHR) ,by Application (Diabetes, Asthma, Heart Disease, Obesity, COPD, Smoking, Drug Non Adherence, Mental Health) ,by Region (North America, Latin America, Europe, Asia Pacific, Middle East And Africa) – Size, Share, Outlook And Opportunity Analysis 2019-2027
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire